This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting neurological and psychiatric disorders, such as depression and anxiety, due to its structural properties that interact with specific receptors in the brain. Additionally, it is employed in the development of selective inhibitors for enzymes or proteins involved in disease pathways. Its fluoropyridine moiety enhances binding affinity and metabolic stability, making it valuable in drug discovery and optimization processes.